Anika therapeutics says drawing down $50 mln on existing credit facility

Anika therapeutics - drawing down $50 million on its existing credit facility.anika therapeutics - following drawdown, will have total liquidity of approximately $140 million, comprised of cash and investments on hand.anika therapeutics inc - has no debt maturities through end of 2020, and credit facility matures in october 2022.anika therapeutics inc - co's credit facility also has a $50 million accordion feature that co could potentially access in future.anika therapeutics - exploring other sources of funding aimed at supporting liquidity profile, maintaining business, organizational continuity through pandemic.anika therapeutics - at this time, co does not anticipate disruption to supply of products for patients due to covid-19.anika therapeutics - has also taken measures to minimize disruption to ongoing clinical trials.
ANIK Ratings Summary
ANIK Quant Ranking